Rheumatology in the Middle East in 2017: clinical challenges and research.

about

P2860

Q50108062-75A6A59F-5F97-480C-9635-F4CF5B1E13CD

P2860

Rheumatology in the Middle East in 2017: clinical challenges and research.

Item

http://www.wikidata.org/entity/Q42333094

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Rheumatology in the Middle East in 2017: clinical challenges and research.

@en

Rheumatology in the Middle East in 2017: clinical challenges and research.

@nl

type

Item

label

Rheumatology in the Middle East in 2017: clinical challenges and research.

@en

Rheumatology in the Middle East in 2017: clinical challenges and research.

@nl

prefLabel

Rheumatology in the Middle East in 2017: clinical challenges and research.

@en

Rheumatology in the Middle East in 2017: clinical challenges and research.

@nl

P1476

Rheumatology in the Middle East in 2017: clinical challenges and research.

@en

P2093

Jamal Al-Saleh

http://www.w3.org/2001/XMLSchema#string

Merav Lidar

http://www.w3.org/2001/XMLSchema#string

P2860

The global challenges and opportunities in the practice of rheumatology: white paper by the World Forum on Rheumatic and Musculoskeletal Diseases.

Bibliometric analysis of rheumatology research in the Arab countries

Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study.

Hypothyroidism among SLE patients: Case-control study.

Development and initial validation of international severity scoring system for familial Mediterranean fever (ISSF).

Registry of the clinical characteristics of spondyloarthritis in a cohort of Egyptian population.

Does inflammatory bowel disease coexist with systemic lupus erythematosus?

Elevated C-Reactive Protein Level Predicts Earlier Treatment with Tumor Necrosis Factor-Alpha Inhibitors in Psoriatic Arthritis.

Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial.

Therapy with eculizumab for patients with CD59 p.Cys89Tyr mutation.

P2888

s13075-017-1359-0

P304

149

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1186/S13075-017-1359-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Yehuda Shoenfeld

Abdulla Watad

Howard Amital

P577

2017-06-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28666485

http://www.w3.org/2001/XMLSchema#string

P921

Middle East

P932

5493117

http://www.w3.org/2001/XMLSchema#string

Rheumatology in the Middle East in 2017: clinical challenges and research.

about

P2860

P2860

Rheumatology in the Middle East in 2017: clinical challenges and research.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932